Enhanced replication of hcv rna
CA 2416633 C · Owner: Lu, Hui-Hua · Inventors: Lu, Hui-Hua; Selby, Mark
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention provides methods for generating cells that stably replicate subgenomic virus replicons. This invention also provides methods of generating cells that have disabled PKR activity and that stably replicate HCV subgenomic replicons. The invention also provides methods of using the cells of the invention to screen for compounds that modulate viral RNA replication including HCV RNA replication.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 3, 2001 and granted April 30, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 3, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 3, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.